The Science Behind Targeted Treatments and Immunotherapies for Bowel Cancer
Format: This is a live, virtual event. Each morning’s content is split over three sessions of 30-40 minutes each. Elaine will be online throughout both mornings to interact with learners and answer questions in the live Q&A sessions that follow each presentation. Recordings of the presentations will be available online for 30 days after the live event.
Description: In this course Elaine provides an up-to-date overview of bowel cancer biology and genetics and the science behind various treatment approaches. Including monoclonal antibodies targeting EGFR, and small molecule such as B-Raf inhibitors. She also describes the rationale behind checkpoint inhibitors for selected patients, and discusses treatment approaches in trials.
Elaine’s goal is to explain the science that underpins each treatment and to provide learners with a broad understanding of why treatments work well for some patients but not for others.
Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine’s other courses
To book, contact: firstname.lastname@example.org